A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2011
03/23/2011	EP2298355A2 Albumin fusion proteins
03/23/2011	EP2298354A2 Remodelling and glycoconjugation of interferon-beta
03/23/2011	EP2298350A2 Composition comprising an inducing agent and an anti-viral agent for the treatment of viral disorders
03/23/2011	EP2298338A1 Lactoferrin compositions and methods of treatment of skin wounds
03/23/2011	EP2298337A2 Regulation of food preference using GLP-1 agonists
03/23/2011	EP2298336A2 Promotion of epithelial regeneration
03/23/2011	EP2298335A1 Use of morphogenic proteins for treating cartilage defects
03/23/2011	EP2298334A2 Tweak receptor
03/23/2011	EP2298333A2 Tweak receptor
03/23/2011	EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response
03/23/2011	EP2298331A2 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
03/23/2011	EP2298301A2 Medicaments for increasing endogenous Erythropoietin (EPO)
03/23/2011	EP2298299A2 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
03/23/2011	EP2298287A2 Stabilised compositions of factor VII polypeptides
03/23/2011	EP2298278A1 Prevention and reduction of blood loss
03/23/2011	EP2297302A1 Method of inducing proliferation and/or differentiation of neural precursor cells by introducing prolactin or wnt3a to activate latent neural precursor cells
03/23/2011	EP2297197A1 Modified erythropoietin (epo)polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof
03/23/2011	EP2297196A1 Vaccine against amyloid folding intermediate
03/23/2011	EP2297195A2 Antibacterial peptides
03/23/2011	EP2297194A1 Method of generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins
03/23/2011	EP2297193A1 Histamine binding protein
03/23/2011	EP2297185A1 Parvoviral capsid with incorporated gly-ala repeat region
03/23/2011	EP2297179A1 Peptide analogues, particularly for the treatment of chronic pain
03/23/2011	EP2297178A2 Peptide analogs of alpha-melanocyte stimulating hormone
03/23/2011	EP2296695A1 Nanoparticles containing proteolytic enzymes for the treatment of peyronie's disease
03/23/2011	EP2296694A2 Neutralizing proprotein convertase subtilisin kexin type 9 (pcsk9) variants and uses thereof
03/23/2011	EP2296692A2 Isoform-specific insulin analogues
03/23/2011	EP2296691A1 Use of pegylated type iii interferons for the treatment of hepatitis c
03/23/2011	EP2296690A2 Fgf21 mutants and uses thereof
03/23/2011	EP2296689A1 Methods of treatment utilizing binding proteins of the interleukin-21 receptor
03/23/2011	EP2296688A2 Peptide vaccine for influenza virus
03/23/2011	EP2296687A2 Pharmaceutical compositions of somatostatin-dopamine conjugates
03/23/2011	EP2296686A1 Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
03/23/2011	EP2296685A1 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
03/23/2011	EP2296684A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
03/23/2011	EP2296683A2 Methods of treating inflammatory intestinal disease and managing symptoms thereof
03/23/2011	EP2296678A1 Modulating interstitial pressure and oncolytic viral delivery and distribution
03/23/2011	EP2296673A1 Colostrum-derived fraction for wound healing and skin care
03/23/2011	EP2296672A1 Conditioned medium of liver progenitor cells
03/23/2011	EP2296647A2 Pai-1 expression and activity inhibitors for the treatment of ocular disorders
03/23/2011	EP2296643A1 Nutritional composition for improving the mammalian immune system
03/23/2011	EP2296632A2 Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders
03/23/2011	EP2019837B1 Compounds and compositions as channel activating protease inhibitors
03/23/2011	EP1919944B1 Modified vegf and pdgf with improved angiogenic properties
03/23/2011	EP1891093B1 Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins
03/23/2011	EP1772145B1 Method of effectively using medicine and method concerning prevention of side effect
03/23/2011	EP1706132B1 A composition for cartilage therapeutics and using method thereof
03/23/2011	EP1691844B1 Methods and compositions for treatment of interferon-resistant tumors
03/23/2011	EP1666591B1 Cytokine that induces apoptosis
03/23/2011	EP1631305B1 Sincalide formulations
03/23/2011	EP1592471B1 Injection device with rotatable dose setting mechanism
03/23/2011	EP1552462B1 Methods of treating and preventing colitis involving il-13 and nk-t cells
03/23/2011	EP1515741B1 Use of collagen hydrolysate to lower the viscosity of a composition comprising guar gum
03/23/2011	EP1469878B1 Fgfr agonists
03/23/2011	EP1446101B1 Catheter injectable depot compositions and uses thereof
03/23/2011	EP1351707B1 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
03/23/2011	EP1320386B1 A novel cationic lipopolymer as biocompatible gene delivery agent
03/23/2011	EP1320377B1 Hla binding peptides and their uses
03/23/2011	EP1285004B1 method of producing synthetic peptides
03/23/2011	CN1893981B Methods and compositions for treatment of interferon-resistant tumors
03/23/2011	CN101990547A Il-23 receptor antagonists and uses thereof
03/23/2011	CN101990544A Synthetic peptides used for treating the skin and use thereof in cosmetic or dermopharmaceutical compositions
03/23/2011	CN101990450A Use of lipid-rich nutrition for the treatment of post-operative ileus
03/23/2011	CN101990438A Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species
03/23/2011	CN101990437A Stable aqueous cyclosporin compositions
03/23/2011	CN101990425A Compositions containing cyclic peptides and methods of use
03/23/2011	CN101988071A Hepatitis c virus vaccine
03/23/2011	CN101988057A Promoter and application thereof
03/23/2011	CN101987873A P53 fusion protein and application thereof
03/23/2011	CN101987868A Derivative or pharmaceutically acceptable salt of GLP-1 analogue and application of derivative or pharmaceutically-acceptable salt of a GLP-1 analogue
03/23/2011	CN101987866A Staphylococcus aureus Efb protein C-end antigen epitope, as well as preparation method and usage thereof
03/23/2011	CN101987865A Antagonist of luteinizing hormone releasing hormone (LHRH) containing hydantoin structure
03/23/2011	CN101987200A Compound medicine containing antihypertensive peptide and aldosterone receptor antagonist for curing hypertension
03/23/2011	CN101987196A Ocytocic for inducing stichopus japonicus to lay eggs in vivo
03/23/2011	CN101987195A Reduced glutathione medicine absorbed through oral mucosa
03/23/2011	CN101987113A Thickening and stable animal iron-supplement composition
03/23/2011	CN101601646B Nasal cavity drop for treating diabetes and preparation method thereof
03/23/2011	CN101439047B Technological process for improving stable FVII yield of human prothrombin complexes
03/23/2011	CN101428136B Uses of recombinant protein in preparing oral medication for preventing diabetes
03/23/2011	CN101422431B Insulation administration preparation through nose
03/23/2011	CN101372512B Anticoagulated blood polypeptides and uses thereof
03/23/2011	CN101328221B Hypoglycemic polypeptide fused protein, structure and use of derivate thereof
03/23/2011	CN101274099B Method for preparing polymer matrix with transfer function
03/23/2011	CN101269215B Glucoprotein incretion composition
03/23/2011	CN101263861B Preparation animal protolysate
03/23/2011	CN101070350B Intensified fusion protein NGR-LDP-AE formed by target peptide to CD13 and lidamycin
03/22/2011	US7910714 Monomeric red fluorescent proteins
03/22/2011	US7910712 Fungal cell wall synthesis gene
03/22/2011	US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders
03/22/2011	US7910706 Humanized neutralizing antibodies against hemolytic uremic syndrome
03/22/2011	US7910704 Human p53 splice variant displaying differential transcriptional activity
03/22/2011	US7910698 NPC1L1 orthologues
03/22/2011	US7910696 Ssx-2 peptides presented by hla class II molecules
03/22/2011	US7910695 Methods for arbitrary peptide synthesis
03/22/2011	US7910694 Homing peptides to receptors of heart vasculature
03/22/2011	US7910693 Prostate cancer diagnosis and treatment
03/22/2011	US7910692 Immunogenic peptides and methods of use
03/22/2011	US7910626 Use of S1P receptor agonists in heart diseases
03/22/2011	US7910580 Antitumor agents, anticancer agents; synergistic mixture; side effect reduction; inhibiting tumor growth in cancer patient by administering a combination therapy comprising 5-Fluorouracil (5-FU) and a methylol transfer agent capable of enhancing antineoplastic effect of 5-FU
03/22/2011	US7910563 Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA

1 ... 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 ... 3163